{"abstract": "Carl C. Icahn, the billionaire investor and chairman of biotechnology company ImClone Systems fired off a letter to the chief executive of Bristol-Myers Squibb, calling Bristol\u2019s revised take-over offer of $62 a share \u201cabsurd.\u201d", "web_url": "https://dealbook.nytimes.com/2008/09/24/icahn-calls-new-bristol-bid-for-imclone-absurd/", "snippet": "", "lead_paragraph": "Carl C. Icahn, the billionaire investor and chairman of biotechnology company ImClone Systems fired off a letter to the chief executive of Bristol-Myers Squibb, calling Bristol\u2019s revised take-over offer of $62 a share \u201cabsurd.\u201d", "source": "The New York Times", "multimedia": [], "headline": {"main": "Icahn Calls New Bristol Bid For ImClone \u2018Absurd\u2019", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-09-24T11:13:06+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/123f5cdd-d325-5cb4-b0ac-8f5961bac185", "word_count": 272, "uri": "nyt://article/123f5cdd-d325-5cb4-b0ac-8f5961bac185"}